IRMD - IRadimed Corporation

IRADIMED CORPORATION to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

ORLANDO, Fla., May 20, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD), a leader in developing innovative MRI-compatible medical devices, today announced that Roger Susi, President and Chief Executive Officer, and Jack Glenn, Chief Financial Officer, will attend the Goldman Sachs 47th Annual Global Healthcare Conference, to be held June 8–10, 2026, at the Loews Miami Beach Hotel, Miami Beach, Florida.

May 20, 2026 04:30 AM • globenewswire.com

Why Iradimed Stock Topped the Market Today

Yet again, it posted growth and robust profitability in its latest quarter.

May 01, 2026 03:48 PM • fool.com

iRadimed Corp (IRMD) Shares Surge 4.4% -- What GF Score of 95 Tells Investors

On May 01, 2026, iRadimed Corp (IRMD) shares rose 4.4%, bringing the current price to $87.15. This movement comes amid a 52-week range that has seen a high of $

May 01, 2026 02:25 PM • gurufocus.com

IRADIMED CORPORATION (IRMD) Q1 2026 Earnings Call Transcript

IRADIMED CORPORATION (IRMD) Q1 2026 Earnings Call Transcript

May 01, 2026 02:11 PM • seekingalpha.com

iRadimed (IRMD) Beats Q1 Earnings and Revenue Estimates

iRadimed (IRMD) came out with quarterly earnings of $0.49 per share, beating the Zacks Consensus Estimate of $0.45 per share. This compares to earnings of $0.42 per share a year ago.

May 01, 2026 06:45 AM • zacks.com

IRADIMED CORPORATION Reports First Quarter 2026 Financial Results

Announces Regular Quarterly Cash Dividend of $0.20 Per Share Reaffirms Full-Year 2026 Revenue and Earnings Guidance  Reports revenue of $22.0 million for the first quarter of 2026, an increase of $2.5 million, or 13%, compared to the same period in 2025. Reports record GAAP diluted EPS of $0.45 and non-GAAP diluted EPS of $0.49 for the first quarter of 2026, which are increases of 22% and 17%, respectively, compared to the same period in 2025.

May 01, 2026 04:30 AM • globenewswire.com

IRADIMED CORPORATION to Hold First Quarter 2026 Financial Results Conference Call on May 1, 2026

ORLANDO, Fla., April 27, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2026 first quarter financial results before the market opens on Friday, May 1, 2026. Iradimed management will host a conference call the same day beginning at 11:00 a.m. Eastern Time to discuss those results and to answer questions.

Apr 27, 2026 04:30 AM • globenewswire.com

IRADIMED CORPORATION to Participate at the 25th Annual Needham Virtual Healthcare Conference

ORLANDO, Fla., April 10, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) today announced that it will participate in the 25th Annual Needham Virtual Healthcare Conference.

Apr 10, 2026 11:14 AM • globenewswire.com

Roger Susi Sells 5,000 Shares of iRadimed (NASDAQ:IRMD) Stock

iRadimed Corporation (NASDAQ: IRMD - Get Free Report) CEO Roger Susi sold 5,000 shares of iRadimed stock in a transaction on Monday, April 6th. The shares were sold at an average price of $96.02, for a total transaction of $480,100.00. Following the sale, the chief executive officer directly owned 2,220,000 shares of the company's stock, valued

Apr 09, 2026 12:03 AM • defenseworld.net

Roger Susi Sells 5,000 Shares of iRadimed (NASDAQ:IRMD) Stock

iRadimed Corporation (NASDAQ: IRMD - Get Free Report) CEO Roger Susi sold 5,000 shares of the stock in a transaction that occurred on Monday, March 23rd. The stock was sold at an average price of $100.38, for a total value of $501,900.00. Following the completion of the transaction, the chief executive officer directly owned 2,235,000 shares

Mar 27, 2026 12:22 AM • defenseworld.net

3 Medical Instrument Stocks Tapping GenAI to Navigate Industry Woes

GMED, TCMD and IRMD tap GenAI to boost diagnostics and workflows, but high costs, regulation gaps and macro pressures still weigh on MedTech growth.

Mar 23, 2026 07:20 AM • zacks.com

IRADIMED CORPORATION to Participate at the 38th Annual Roth Conference

ORLANDO, Fla., March 16, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) today announced that it will participate in the 38 th Annual Roth Conference.

Mar 16, 2026 10:00 AM • globenewswire.com

5 Medical Instruments Stocks to Buy Amid Huge Short-Term Price Upside

ISRG, GMED, EW, ALC and IRMD show strong short-term upside as AI tools, acquisitions and new product pipelines fuel growth.

Mar 10, 2026 06:36 AM • zacks.com

Principal Financial Group Inc. Acquires New Holdings in iRadimed Corporation $IRMD

Principal Financial Group Inc. bought a new position in iRadimed Corporation (NASDAQ: IRMD) in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 5,927 shares of the medical equipment provider's stock, valued at approximately $422,000. Several other hedge funds have also modified their

Feb 19, 2026 10:20 PM • defenseworld.net

IRadimed Stock Up 80% in One Year as Fund Sells $29 Million Stake Amid Record Quarter

Nine Ten Capital Management sold 342,907 shares of IRadimed; the estimated transaction value was $29.42 million based on quarterly average price. The quarter-end position value decreased by $13.21 million, reflecting both share sales and price changes.

Feb 17, 2026 08:53 AM • fool.com

Why Iradimed Stock Soared Today

For the 18th time in a row, the niche medical device maker set a new all-time high for quarterly revenue. It also handily topped the consensus analyst estimate for adjusted net profit.

Feb 10, 2026 12:12 PM • fool.com

IRADIMED CORPORATION (IRMD) Q4 2025 Earnings Call Transcript

IRADIMED CORPORATION (IRMD) Q4 2025 Earnings Call Transcript

Feb 10, 2026 08:14 AM • seekingalpha.com

IRADIMED CORPORATION Reports Record Fourth Quarter and Full Year of 2025 Financial Results and Increases its Regular Quarterly Cash Dividend to $0.20 Per Share from $0.17 Per Share

ORLANDO, Fla., Feb. 10, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company” or “Iradimed”) (NASDAQ: IRMD) announced today its financial results for the quarter and year ended December 31, 2025. The Company is a leader in developing innovative magnetic resonance imaging (“MRI”) compatible medical devices and products. The Company is a provider of (i) non-magnetic intravenous (“IV”) infusion pump systems and (ii) non-magnetic patient vital signs monitoring systems that are each designed for use during MRI procedures.

Feb 10, 2026 03:00 AM • globenewswire.com

iRadimed Corporation (NASDAQ:IRMD) Given Average Rating of “Moderate Buy” by Analysts

Shares of iRadimed Corporation (NASDAQ: IRMD - Get Free Report) have been given an average rating of "Moderate Buy" by the five research firms that are presently covering the firm, MarketBeat reports. One analyst has rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 1-year price

Jan 20, 2026 01:13 AM • defenseworld.net

iRadimed price target raised to $120 from $100 at Lake Street

$120.00 (was $106.02)

Lake Street

Feb 11, 2026 08:44 AM • TheFly

iRadimed price target raised to $120 from $98 at Roth Capital

$120.00 (was $105.15)

Roth Capital

Feb 10, 2026 03:36 PM • TheFly

iRadimed price target raised to $98 from $90 at Roth Capital

$98.00 (was $84.11)

Kyle Bauser · Roth Capital

Nov 03, 2025 03:10 PM • TheFly

iRadimed price target raised to $100 from $75 at Lake Street

$100.00 (was $84.11)

Lake Street

Nov 03, 2025 01:28 PM • TheFly

iRadimed resumed with a Buy at Roth Capital

$90.00 (was $76.42)

Kyle Bauser · Roth Capital

Oct 31, 2025 04:24 AM • TheFly

iRadimed price target lowered to $60 from $65 at Roth MKM

$60.00 (was $46.15)

Jason Wittes · Roth Capital

Aug 02, 2024 04:40 AM • TheFly

Lake Street Capital Markets Reiterates Buy Rating on IRadimed Corp (IRMD)

$60.00 (was $43.28)

Frank Takkinen · Loop Capital Markets

Jun 17, 2024 05:49 AM • StreetInsider